RE: RE: RE: I'm beginning to think-Graeme should consider putting the CEO of Bioniche Pharm on the BNC board so we can tap into his expertise to get the max. value out of what we have in MCC. Can you imagine what he can do for MCC after seeing what he got out of Bioniche Pharma which has no new drugs but only an injectable platform?
The problem with BNC is that they really have a crush with animals. Their whole thinking pattern is to do good for the animals. That mentality comes through loud and clear. Unfortunately, the investment does not share the same enthusiasm for animal health. At least in terms of out look in profitability. That's why BNC just does not get the respect and notice as the MCC platform and Urocidin deserves. I bet if BNC break out the MCC and Urocidin break out into a new independent company, it will get much better market response.
I am still perplexed why BNC exec team would invest so much into the Econiche vaccine without exploring the probability of government mandate and food producers readiness to take up the cost first. Now we do have a good product. But without market demand, it is only a great window dressing. Good for their do-gooder conscience but not much else. It is reflected in the sp
The neutralceuticsis another example of their animal love. Neutralceutic is just beginning to be recognised by human health field and still requires a long time to become main-stream. BNC sees animals as human and can't wait to jump into it. Luckily, it is not costing us a lot of money, Just another distraction.
OK, I am done with my ranting.